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ABSTRACT 
Glycoside phosphorylases (GPs) are interesting enzymes for the glycosylation of chemical 
molecules. They only require a glycosyl phosphate as sugar donor and an acceptor molecule 
with a free hydroxyl group. Their narrow substrate specificity, however, limits the application 
of GPs for general glycoside synthesis. Although an enzyme’s substrate specificity can be 
altered and broadened by protein engineering and directed evolution, this requires a suitable 
screening assay. Such a screening assay has not yet been described for GPs. Here, we report a 
screening procedure for GPs based on the measurement of released inorganic phosphate in the 
direction of glycoside synthesis. It appeared necessary to inhibit endogenous phosphatase 
activity in crude Escherichia coli cell extracts with molybdate, and inorganic phosphate was 
measured with a modified phosphomolybdate method. The screening system is general and 
can be used to screen GP enzyme libraries for novel donor and acceptor specificities. It was 
successfully applied to screen an E649 saturation mutagenesis library of Cellulomonas uda 
cellobiose phosphorylase (CP) for novel acceptor specificity. An E649C enzyme variant was 
found with novel acceptor specificity towards alkyl β-glucosides and phenyl β-glucoside. This 
is the first report of a CP enzyme variant with modified acceptor specificity. 
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Glycosylation can significantly influence the properties of a molecule [1]. In the case of 
pharmaceuticals, glycosylation can improve the pharmacokinetic properties of a drug and 
induce drug targeting to specific organs, resulting in less side effects and smaller doses [2]. 
Glycoside phosphorylases (GPs) such as sucrose phosphorylase (SP) and cellobiose 
phosphorylase (CP) are promising enzymes for glycoside synthesis since they do not require 
expensive nucleotide-activated sugars as glycosyl donor but instead use a glycosyl phosphate 
(e.g. α-glucose 1-phosphate) [3]: 
R-OH (acceptor)   +    glycosyl phosphate (donor)        R-glycoside    +    Pi 
Furthermore, since GPs catalyze reversible reactions, the glycosyl phosphate donor can be 
easily obtained by enzymatic phosphorolysis of a simple sugar such as sucrose or lactose [4; 
5]. Several unnatural trisaccharides and disaccharides with potential prebiotic effect could be 
synthesized with cellobiose phosphorylase (CP) [6; 7], and natural sucrose phosphorylase 
(SP) from Bifidobacterium longum has been used for the glycosylation of vitamin C, resulting 
in the more stable 2-O-α-D-glucopyranosyl-L-ascorbic acid [8]. 
 The relatively narrow substrate specificity of GPs, however, limits their use for a 
general glycosylation technology. A possible solution is to optimize the enzymes by protein 
engineering, and more specifically via directed evolution. In this technique, enzyme libraries 
are created by mutagenesis of the DNA encoding the enzyme of interest, followed by 
recombinant expression in e.g. Escherichia coli and screening for improved variants with a 
high-throughput screening (HTS) system. Typically hundreds to thousands of enzymes 
variants need to be screened in order to find improved mutants [9]. Reports of directed 
evolution on GPs are very limited, possibly due to the lack of a suitable HTS system. We have 
previously created Cellulomonas uda CP enzyme variants with modified donor specificity that 
were found using a selection and screening system based on the release of glucose from 
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lactose phosphorolysis [10]. However, this screening system is not suitable for identifying 
enzyme variants with modified acceptor specificity and is not generally applicable to other 
GPs. Therefore, the availability of a general high-throughput screening systems for GPs is 
highly desirable since it would accelerate the development of enzyme variants with modified 
substrate specificity towards various aglycons. 
 Independent of their substrate specificity, GPs have the common feature that they 
release inorganic phosphate in the direction of glycoside synthesis using glycosyl phosphate 
as glycosyl donor. The amount of released phosphate is directly related to enzyme activity. 
Many methods have been described for the measurement of inorganic phosphate, and most of 
them are based on the method of Fiske and Subbarow [11]. In this method, a 
phosphomolybdate complex is reduced under acidic conditions resulting in the formation of a 
molybdenum blue compound which can be measured spectrophotometrically. The original 
method could be improved using ascorbic acid as a reducing agent instead of ferrous sulfate 
and by adding stop solution to stop color development which is useful in the presence of acid-
labile organic phosphates [12]. The assay is cheap, fast, sensitive and robust, and thus 
convenient for high-throughput screening. 
 Here, we report on the development of a high-throughput screening system for GPs, 
based on the measurement of released inorganic phosphate when an acceptor molecule is 
glycosylated. It appeared necessary to inhibit endogenous E. coli phosphatase activity in 
crude cell extracts because it causes high background values and consumes the glycosyl 
phosphate substrate. For the measurement of inorganic phosphate, a modified 
phosphomolybdate method was developed based on the method of Gawronski and Benson 
[12] and the screening procedure was evaluated using C. uda CP as a model. CP uses α-
glucose 1-phosphate (αGlc1P) as glycosyl donor and glucose as acceptor. The acceptor 
specificity of C. uda CP is relatively narrow in comparison to other GPs and furthermore, 
5 
there is a strict specificity for a free anomeric hydroxyl group with glucose as acceptor [3; 
13]. Since this is a serious limitation for general glycosylation applications, our first aim was 
to eliminate this requirement in CP. Residue E649 is located near the acceptor binding site 
and was hypothesized to be important for substrate specificity. Screening of an E649 
saturation library with a substrate mix composed of several acceptors identified an E649C 
enzyme variant with modified acceptor specificity towards alkyl β-glucosides and phenyl β-
glucoside. 
 
MATERIALS AND METHODS 
Bacterial strains, plasmids and growth conditions 
The pXCP expression vector encoding C. uda cellobiose phosphorylase has been described 
earlier [10]. Escherichia coli XL10-Gold cells (Stratagene, USA) were used for protein 
expression. E. coli containing plasmid was routinely grown overnight at 37 °C and 200 rpm in 
LB medium (10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl, pH 7.0) supplemented with 100 
mg/L ampicillin. All chemicals were from Sigma, except for ethyl β-glucoside and octyl β-
glucoside which were purchased from Carbosynth (UK). 
 
Protein expression 
E. coli XL10-Gold was transformed with the expression vector and a colony was picked and 
grown overnight. The overnight culture was used to inoculate fresh medium and expression of 
the recombinant enzyme was induced by adding IPTG to a final concentration of 0.1 mM 
when the optical density at 600 nm (OD600) of the culture reached 0.6. After 6 hours of 
induction, 1 mL samples of the culture (OD600~4.0) were centrifuged for 10 minutes at 
15,000 x g and the pellets were frozen at -20°C.  
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Inhibition of E. coli phosphatase activity 
Crude cell extracts were prepared by enzymatic lysis of frozen E. coli XL10-Gold/pXCP 
pellets using the EasyLyse Bacterial Protein Extraction Solution (Epicentre, USA). These cell 
extracts were then used to optimize phosphatase inhibitor concentrations. Enzyme reactions 
were carried out at 37 °C with 5% of crude cell extract and 30 mM of αGlc1P in 50 mM Mes-
buffer, pH 6.6. As a test for phosphatase inhibition, different concentrations of potassium 
fluoride (KF; 0-50 mM) and sodium molybdate (Na2MoO4; 0-500 mM) were added. Assays 
were carried out in triplicate and phosphatase activity was measured by determining the 
amount of released glucose per unit of time with the Biochemistry Analyzer 2700 Select 
(YSI). 
 
Determination of inorganic phosphate 
The determination of inorganic phosphate in the presence of acid-labile organic phosphate 
was based on the method of Gawronski and Benson [12], but had to be modified because 
molybdate was already present as phosphatase inhibitor in the reaction mixture. In the original 
method, a color solution is prepared by mixing 2 parts of 12% (w/v) ascorbic acid in 1 N HCl 
with 1 part of 2% (w/v) ammonium molybdate tetrahydrate ((NH4)6Mo7O24.4H2O). One 
hundred fifty microliter of this color solution is added to 50 µL of sample and incubated for 5 
minutes. If phosphate is present, a blue color develops. Afterwards, 150 µL of stop solution 
(2% (v/v) acetic acid, 2% (w/v) sodium citrate tribasic dihydrate) is added and the absorbance 
is read at 655 nm with a Bio-Rad 680XR microtiter plate reader. The method is linear up to 2 
mM phosphate present in the sample.  
 The original method was modified to be compatible with the screening protocol by 
omitting molybdate from the color solution and by varying the concentration of ascorbic acid 
(12%-5%-0.24%) and HCl (0-0.1-0.5-1 N) in the color solution. A phosphate standard curve 
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ranging from 0-3 mM in 50 mM Mes buffer (pH 6.6) containing 200 mM sodium molybdate 
was used for optimization and three replicates were performed for each standard curve point. 
The optimized color solution in the modified method was composed of 0.24% (w/v) ascorbic 
acid in 0.1 N HCl solution, and 150 µL is added to a 50 µL sample containing 200 mM 
sodium molybdate. The subsequent steps are the same as in the original method. 
 
Site-saturation mutagenesis 
Site-saturation mutagenesis of residue E649 in the C. uda cellobiose phosphorylase gene was 
performed with the QuikChange
®
 Multi Site-Directed Mutagenesis Kit (Stratagene, USA). 
The pXCP expression vector was used as template (150 ng) and 100 ng of primer was used. 
The sequence of the degenerate primer was as follows: 
5’-CCAGGTGCACATGGGCNNSGTCTCCACGTACCCGC-3’. 
 It contains the NNS codon encoding all possible 20 amino acids and one stop codon. 
Thermal cycling was performed in a 25 µL reaction volume containing 4% of QuikSolution, 
with the following cycling conditions: 95 °C (3 min); 30 cycles of 95 °C (1 min), 55 °C (1 
min) and 65 °C (14 min). After the reaction, 10 units of DpnI restriction enzyme were added 
to the reaction mixture and incubated for 6 hours at 37 °C to completely digest parental 
template DNA. The PCR mixture was transformed into E. coli XL10-Gold and the 
transformation mixture was plated on a Qtray (Genetix, UK) containing LB-agar medium 
supplemented with ampicillin. 
 
Screening procedure 
Colonies were picked with a QPix2 robotic colony picker (Genetix, UK) and inoculated into 
96-well flat-bottomed microtiter plates containing 175 µL LB medium per well, supplemented 
with ampicillin. The microtiter plates were incubated for 16 hours at 37°C and 250 rpm. 
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Recombinant enzyme expression was then induced by inoculation of the grown mini-cultures 
into new microtiter plates containing 175 µL LB medium per well, supplemented with 
ampicillin and 0.1 mM IPTG. After incubation for 16 hours at 37°C and 250 rpm, the 
microtiter plates were centrifuged at 1,500 x g for 10 minutes, and the pellets were frozen at -
20°C. The following steps were all carried out on a Tecan Freedom EVO 200 liquid handling 
robot. The pellets were lysed with 100 µL of lysis buffer composed of 50 mM Tris-HCl (pH 
7.5), 1 mM EDTA, 0.5% Triton X-100, 4 mM MgCl2, 50 mM NaCl and 1 mg/mL lysozyme. 
Lysis was carried out for 30 minutes at 37°C. After lysis, the plates were centrifuged at 3,000 
x g for 10 minutes and the supernatants (crude cell extracts) were used for screening. Enzyme 
reactions were carried out at 37°C in microtiter plates by mixing 30 µL crude cell extract with 
170 µL substrate solution. For screening of the E649 saturation library the reaction mixture 
contained 50 mM Mes-buffer (pH 6.6), 200 mM sodium molybdate, 30 mM αGlc1P, and an 
acceptor mix containing 100 mM each of methyl α-glucoside, methyl β-glucoside, sucrose 
and fructose. After 3 hours of incubation, 50 µL samples were taken from the reaction 
mixtures and transferred to a new microtiter plate to determine the amount of released 
phosphate. One hundred fifty microliter of a 0.24% ascorbic acid in 0.1 N HCl solution was 
added to the sample and incubated for 5 minutes at room temperature. Afterwards, 150 µL of 
stop solution (2% acetic acid, 2% citric acid) was added and absorbance at 655 nm was 
measured with a microplate reader. Positive clones were grown for plasmid extraction and 
sequenced to identify their mutations. 
 
Characterization of enzyme variants 
For an initial characterization of wild-type CP and the improved variant, the corresponding 
expression vector was used to transform E. coli XL10-Gold and the enzyme was expressed as 
described before. Crude cell extracts were prepared using the EasyLyse kit (Epicentre, USA). 
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To determine acceptor specificity, enzyme reactions were carried out at 37 °C with 5% (v/v) 
crude cell extract and substrate solution composed of 50 mM Mes-buffer (pH 6.6), 200 mM 
sodium molybdate, 30 mM αGlc1P and 100 mM of acceptor (either methyl β-glucoside, ethyl 
β-glucoside, octyl β-glucoside, methyl α-glucoside, sucrose or fructose). Samples were taken 
at regular time intervals and inactivated at 95 °C for 5 minutes. Inorganic phosphate release 
was determined with the modified phosphomolybdate method (see earlier).  
 Wild-type C. uda CP and the E649C enzyme variant were purified as described earlier 
[14], and their kinetic parameters were determined. Michaelis-Menten parameters on various 
acceptors were determined by incubating purified enzyme with a fixed concentration of 
αGlc1P (30 mM) and various concentrations of acceptor in 50 mM Mes-buffer (pH 6.6) at 37 
°C. Initial reaction velocities were determined by measuring the amount of released inorganic 
phosphate using the original phospomolybdate method [12]. The kcat value was calculated 
assuming a molecular mass of 91.4 kDa for the catalytic unit (one monomer). Protein 




Inhibition of phosphatase activity in E. coli cell extracts 
When crude E. coli/pXCP cell extracts were incubated with αGlc1P, significant glucose and 
phosphate release was observed. This is due to hydrolysis of the phosphate-ester bond by E. 
coli phosphatases present in the crude cell extract. Phosphatase activity interferes with 
phosphorylase activity because it consumes the glycosyl donor molecule and produces 
phosphate which causes high background levels in the inorganic phosphate assay. Therefore it 
was necessary to inhibit phosphatase activity. Although several phosphatase inhibitors have 
been described in literature, most of them are not useful here because they can also inhibit 
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phosphorylase enzymes, or because they are incompatible with the phosphate determination 
method. For example, vanadate was shown to be an inhibitor of phosphatases [15] but also 
inhibits CP activity [13]. Fluoride and molybdate, both shown to be potent phosphatase 
inhibitors [15; 16; 17], were tested at different concentrations for inhibition of phosphatase 
activity in E. coli/pXCP cell extracts. In the case of fluoride, a maximum inhibition of 70% 
could be achieved at 15 mM (Fig. 1), while for molybdate, more than 90% inhibition was 
observed at concentrations higher than 100 mM (Fig. 2). Cellobiose phosphorylase activity 
was not influenced by these inhibitor concentrations (data not shown). A molybdate 
concentration of 200 mM gave approximately 95% inhibition and was used in further tests. 
 
Determination of inorganic phosphate 
The original Gawronski and Benson method for phosphate determination was successfully 
applied here for phosphate standards ranging from 0 to 2 mM. A standard curve with high 
linearity (A655 = 1.545 x [mM Pi] + 0.051; R²>0.99) was obtained. Ascorbic acid (AA) is 
used for reduction of the phosphomolybdate complex under acidic conditions. Stop solution, 
composed of 2% acetic acid and citrate, is added to prevent further color development caused 
by the release of acid-labile phosphate. The citrate present in the stop solution complexes 
residual molybdate, so that no new phosphomolybdate complexes are formed and no more 
blue color can be produced. 
 In the original Gawronski and Benson method, a final concentration of 37.8 mM 
molybdate is present after the addition of color solution (150 µL) to the sample (50 µL). 
However, when molybdate is used as an inhibitor (at 200 mM) in the sample, a total amount 
of 87.8 mM is present. Since this is more than twice as much as in the original method, it was 
expected that this would influence the test. Therefore, a standard curve of phosphate (0-3 
mM) was made with 200 mM sodium molybdate in every standard. In this case, the original 
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protocol gave unmeasurably high absorbances (A655 >3.5) at phosphate concentrations above 
0.05 mM. Even a blank sample containing no phosphate gave an absorbance higher than 1.0. 
Because it is important to have low background values in screening, and to prevent dilution 
steps in the screening protocol, the method was modified for samples containing 200 mM 
molybdate.  
 A first step was to omit molybdate from the color solution. A color solution of 12% 
AA in 1 N HCl resulted in measurable absorbances between 0 and 1.5 mM phosphate. 
However, the standard curve was not linear under these conditions (Fig. 3). Therefore, we 
decided to vary the concentration of AA (12%; 5%; 0.24%) and HCl (1.0 N; 0.1 N; 0 N) in 
the color solution, using standard solutions of phosphate (0-3 mM) prepared in 200 mM 
molybdate and 50 mM Mes (pH 6.6). The results are shown in Fig. 3. It appeared that higher 
AA and HCl concentrations in the color solution result in a higher sensitivity of the test. 
However, a too sensitive test is not always desirable because it can require dilution steps 
which slow down the screening process. The 12% AA solutions (1.0 N and 0.1 N) and the 5% 
AA/1 N HCl solution were unable to measure a 3 mM phosphate standard. On the other hand, 
the 0.24% AA/1 N HCl solution had an identical slope as that of the 5% AA/0.1 N HCl 
solution, although with a 20 times lower AA concentration. The 0.24% AA/0.1 N HCl 
solution also performed well, with good linearity. In general, all solutions with 0.1 N HCl 
showed greater linearity than the 1.0 N solutions, especially at the higher AA concentrations 
(12% AA and 5% AA). 
 Therefore, we decided to use a color solution composed of 0.24% AA in 0.1 N HCl for 
screening and enzyme tests where molybdate is used as an inhibitor at 200 mM. This color 
solution gives low background values, good linearity, good reproducibility. The stop solution, 
which is necessary to stop color development before release of acid-labile phosphate, did not 
12 
need to be modified. As in the original method, the developed color was stable for several 
hours.  
 
Validation of the screening procedure 
The optimized methods for phosphatase inhibition and inorganic phosphate determination 
were combined in a robotic screening procedure as described in the Materials and Methods 
section. The screening procedure was first validated by screening an E. coli XL10-
Gold/pXCP microtiter plate for CP activity. Since every well contains an identical wild-type 
enzyme, the variation should be as low as possible. The reaction mixture contained 50 mM 
Mes, 200 mM molybdate, 30 mM αGlc1P and 30 mM glucose and the enzyme reaction was 
carried out for 15 minutes. In this case, the coefficient of variance (CV) of the whole 
screening procedure was 10.1% and is thus sufficiently low for use in directed evolution 
experiments [18]. 
 
Screening of a cellobiose phosphorylase E649 saturation library 
The crystal structure of C. gilvus CP has been solved earlier (PDB 2cqt and 2cqs) and 
contains the natural acceptor glucose as a ligand at the acceptor site in the catalytic center 
[19]. Because the CP enzymes of C. gilvus and C. uda show high identity on the amino acid 
level (89%), the available 3D structure was used as a model for the C. uda enzyme. From the 
structure it can be seen that glucose is in the β-configuration and forms a hydrogen bond with 
residue E649, which is located closely to the anomeric hydroxyl group (Figure 4). It was 
already shown that CP enzymes are very specific for the anomeric hydroxyl group and that 
glucose molecules containing a substitution on C-1 are no or very poor acceptors [3; 13]. This 
might be due to the lack of space around the anomeric hydroxyl group because of the 
presence of the glutamate side chain. We hypothesized that mutagenesis of E649 could result 
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in acceptance of C-1 substituted molecules and broaden CP acceptor specificity. Therefore 
saturation mutagenesis was applied on site E649 with the degenerate NNS codon. This results 
in 32 possible genotypes encoding all amino acids plus one stop codon, and requires screening 
of about 94 clones (~3 times oversampling) to have a 95% coverage of the theoretical library 
[20]. 
 An acceptor mix composed of several C-1-substituted glucose molecules was used for 
screening of the E649 library. Methyl α-glucoside, methyl β-glucoside, sucrose and fructose 
were simultaneously present in the substrate solution, each at 100 mM. None of them have 
been reported as acceptor for wild-type C. uda CP. The use of an acceptor mix allows the 
simultaneous and thus fast screening of several substrates, especially in cases where the 
precise effect of an amino acid site on specificity is not known. Ninety-six clones were 
screened for novel acceptor specificity and the result is shown in Fig. 5. Three clones were 
found with significantly improved activity as they gave high absorbance values at 655 nm. 
Sequencing revealed that they all contain the same E649C amino acid substitution, caused by 
a GAG to TGC codon change. Interestingly, no other hits could be observed, suggesting that 
only a limited number of amino acids is suitable on this site for high activity on the acceptor 
mix. Since mutation of glutamate (E) into cysteine (C) requires three consecutive DNA 
mutations, the E649C mutation would be very difficult to obtain by error-prone PCR. This 
illustrates the intrinsic power of saturation mutagenesis combined with semi-rational design. 
 
Substrate specificity of the E649C enzyme variant 
Since a substrate mix was used during screening, enzyme tests were performed to determine 
the modified acceptor specificity of the E649C enzyme variant. Enzyme tests were carried out 
with crude cell extracts of E649C and wild-type C. uda CP, using different acceptors in the 
direction of glycoside synthesis (Table 1). The E649C enzyme variant was found to be active 
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on methyl β-glucoside, but not on methyl α-glucoside, sucrose nor fructose. As expected from 
literature data, wild-type CP did not show detectable activity on any of the tested acceptors, 
except for glucose. For the E649C enzyme variant, the activity on glucose was decreased 10-
fold compared to the wild-type enzyme. Because of its high activity on methyl β-glucoside, it 
was hypothesized that E649C would also be active on longer alkyl β-glycosides. The E649C 
mutant indeed showed activity towards ethyl β-glucoside, although it was only one-third of 
the activity on methyl β-glucoside. No activity was detected with octyl β-glucoside as 
acceptor. Remarkably, the E649C variant was active on phenyl β-glucoside as acceptor (Table 
1). 
 The kinetic parameters of purified wild-type C. uda CP on glucose and of purified 
E649C enzyme on glucose, methyl β-glucoside and ethyl β-glucoside were determined (Table 
2). It appeared that the E649C variant has similar kcat values for all tested acceptors, but that 
the Km values increase drastically with increasing alkyl chain length. For the E649C variant, 
the catalytic efficiency (kcat/ Km) was still highest with glucose as acceptor, although the Km 
value for glucose increased more than 10-fold in comparison with wild-type. This is probably 
due to the loss of the hydrogen bond interaction between the anomeric hydroxyl group of 
glucose and the E649 residue, which was reported to be important for activity [13; 19]. Also 





Measuring inorganic phosphate released by GPs in the direction of glycoside synthesis is a 
convenient way to screen for enzyme variants with modified substrate specificity. The 
advantage is that no substrate-mimics are needed and that any substrate can be tested as donor 
or acceptor molecule without changing the screening protocol. A high-throughput screening 
method for phosphatases based on the identification of released inorganic phosphate in cells 
has been described earlier [21]. However, in some cases, it suffered from low signal-to-
background ratio because of endogenous phosphatase activity, especially when glucose 1-
phosphate was used as a substrate. In the present study, we report inhibition of phosphatase 
activity in crude E. coli cell extracts by the addition of fluoride and molybdate to the substrate 
solution. The high molybdate concentration (200 mM) used as inhibitor in enzyme reactions 
could conveniently be applied for the colorimetric determination of inorganic phosphate. 
Inorganic phosphate determination methods are usually based on the reduction of a 
phosphomolybdate complex under acidic conditions resulting in the formation of a 
molybdenum blue compound. Many variations of the original method described by Fiske and 
Subbarow [11] have been reported [12; 22; 23]. We decided to base our method on that of 
Gawronski and Benson [12] since it was specifically developed for inorganic phosphate 
measurement in the presence of acid-labile organic phosphate compounds (e.g. ATP and 
sugar phosphates). Furthermore, the produced color is stable over a long period of time and 
the absorbance of the molybdenum blue complex can be easily measured at 655 nm in a 
microtiter plate reader. The original method was modified to accommodate the high 
molybdate concentration already present in the sample as phosphatase inhibitor. Our modified 
method is different from others since it requires a relatively low ascorbic acid concentration 
and because molybdate is present in the sample instead of in the color solution. The modified 
inorganic phosphate assay is sensitive enough to detect low enzyme activity but does not 
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require dilution steps in the case of a 15 minute reaction with wild-type CP on its natural 
substrates. This is advantageous for high-throughput screening since dilution steps slow down 
the process and increase the variation. 
 The screening procedure was successfully applied for the detection of CP enzyme 
variants with modified substrate specificity. An E649C enzyme variant with novel acceptor 
specificity towards methyl β-glucoside, ethyl β-glucoside and phenyl β-glucoside, was 
identified by screening of a C. uda CP E649 saturation library. Replacement of the glutamate 
residue by the smaller cysteine residue allows alkyl and aryl β-glucosides to function as 
acceptor probably because more space is created around the anomeric hydroxyl group of 
glucose. If so, it is remarkable that we have found only the E649C beneficial mutation, while 
other small amino acids at site 649 could result in a similar effect. Although it cannot 
completely ruled out that some mutations were missing in our library, there might be also 
another explanation for the apparent preference of cysteine at site 649. Cysteine, commonly 
being classified as a hydrophilic amino acid, actually displays a strong hydrophobic character 
in proteins [24]. Consequently, it might create an optimal microenvironment to accommodate 
the hydrophobic substitutions of the tested β-glucosides, together with the closely located 
C491 residue (Figure 4). Possibly other small and hydrophobic amino acids are less 
appropriate than cysteine in this case. 
 Enzyme characterization revealed that the E649C mutation mainly affects binding of 
glucose and β-glucosides in the active site, rather than the chemical steps of catalysis. The 
kinetic parameters of the C. uda CP E649C variant on methyl β-glucoside are better than 
those of Thermotoga maritima CP, which is the only known CP active on methyl β-glucoside 







were reported on the same acceptor [25]. The biggest difference is observed in the Km value, 
which is 2.4-fold lower for the E649C mutant. There are no reports on the use of longer chain 
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alkyl glycosides as acceptor for T. maritima CP nor other phosphorolytic enzymes. The 
acceptor specificity of E649C towards various alkyl and phenyl β-glucosides allows the 
regiospecific enzymatic synthesis of the corresponding alkyl and phenyl β-cellobiosides, 
which are useful for enzyme studies with cellulases and cellobiases [26; 27]. 
 The discovery of the E649C mutant shows that the screening procedure can be used to 
screen phosphorylase enzyme libraries for novel substrate specificities. The reported high-
throughput screening system is general, and can be used to screen a whole range of different 
substrates, as was demonstrated here by using an acceptor mix composed of different 
molecules. Furthermore, it is also applicable to other GPs or phosphate releasing enzymes. 
The availability of a screening platform should now accelerate the creation of GP enzymes 
with modified substrate specificity towards aglycons such as vitamins and drugs. 
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Table 1. Overview of acceptor specificity of wild-type CP and the E649C mutant. One 
unit (U) of enzyme activity is defined as the amount of enzyme that converts 1 µmole of 




Specific activity cell extracts (U/mg total protein) 
Wild-type E649C 




Methyl β-glucoside - 0.215 
Sucrose - - 
Fructose - - 
Ethyl β-glucoside - 0.055 
Octyl β-glucoside - - 
Phenyl β-glucoside - 0.159 
a 
Acceptors were used at 100 mM each, except for glucose (30 mM) and phenyl β-
glucoside (50 mM); 
b




Table 2. Kinetic parameters of purified C. uda CP and the E649C enzyme variant on several 
acceptors 
Enzyme Acceptor kcat (s
-1







 9.7 ± 0.8 2.1 ± 0.6 4660 
    
E649C variant Glucose
b
 6.3 ± 0.2 28.9 ± 2.3 220 
 Methyl β-glucoside
c
 6.8 ± 0.1 56.6 ± 3.1 120 
 Ethyl β-glucoside
d
 5.1 ± 0.1 155 ± 9.5 33 
Values are obtained from non-linear fits of initial velocities at different substrate 





 4.6-148 mM; 
c
 12-394 mM; 
d




Figure 1. Influence of potassium fluoride concentration on phosphatase activity 
Figure 2. Influence of sodium molybdate concentration on phosphatase activity 
Figure 3. Effect of different compositions of color solution on the absorbances of a phosphate 
standard curve 
Figure 4. View on the C. gilvus CP active site (PDB 2cqt), where E649 forms a hydrogen 
bond with the anomeric hydroxyl group of the glucose acceptor. The catalytic amino acid 
D490, C491, donor (glycerol mimic) and inorganic phosphate are shown as well. 
Figure 5. Screening result of the E649 saturation library (●) and a wild-type CP plate as 
control (∆) on non-native acceptors 
 
 
